Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | ADAM9 |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → ADAM9 |
| (<<) CASP1 → ADAM9 |
| (<<) CASP7 → ADAM9 |
| (<<) CASP9 → ADAM9 |
| (<<) COX6A2 → ADAM9 |
| (<<) CRTC1 → ADAM9 |
| (<<) CSGALNACT2 → ADAM9 |
| (<<) CSNK1E → ADAM9 |
| (<<) DPH2 → ADAM9 |
| (<<) DVL1 → ADAM9 |
| (<<) GNG10 → ADAM9 |
| (<<) HIF1A → ADAM9 |
| (<<) HS2ST1 → ADAM9 |
| (<<) JUND → ADAM9 |
| (<<) KLF10 → ADAM9 |
| (<<) MAFF → ADAM9 |
| (<<) MAP2K2 → ADAM9 |
| (<<) MSN → ADAM9 |
| (<<) PALM → ADAM9 |
| (<<) PRKCSH → ADAM9 |
| (<<) RAP1A → ADAM9 |
| (<<) RBM7 → ADAM9 |
| (<<) RHOQ → ADAM9 |
| (<<) SERPINB1 → ADAM9 |
| (<<) SLMO2 → ADAM9 |
| (<<) UBE2E3 → ADAM9 |
| (<<) YWHAQ → ADAM9 |
| Downstream (Children) |
|---|
| ADAM9 → ARAF (>>) |
| ADAM9 → ARHGEF4 (>>) |
| ADAM9 → BCL2 (>>) |
| ADAM9 → CDCP1 (>>) |
| ADAM9 → CHST2 (>>) |
| ADAM9 → EFNB2 (>>) |
| ADAM9 → EREG (>>) |
| ADAM9 → HDAC11 (>>) |
| ADAM9 → KYNU (>>) |
| ADAM9 → LSM1 (>>) |
| ADAM9 → MAP3K11 (>>) |
| ADAM9 → MAP3K4 (>>) |
| ADAM9 → MAPK6 (>>) |
| ADAM9 → MEF2D (>>) |
| ADAM9 → MMP10 (>>) |
| ADAM9 → NDOR1 (>>) |
| ADAM9 → NOTCH4 (>>) |
| ADAM9 → PHLDA2 (>>) |
| ADAM9 → PIK3CG (>>) |
| ADAM9 → PLCB3 (>>) |
| ADAM9 → PTEN (>>) |
| ADAM9 → RHOF (>>) |
| ADAM9 → RRAS2 (>>) |
| ADAM9 → SF3A2 (>>) |
| ADAM9 → SMAD3 (>>) |
| ADAM9 → ST3GAL2 (>>) |
| ADAM9 → ZNF224 (>>) |
